Contemporary approaches for the laboratory diagnosis of Clostridium difficile infections

Seminars in Colon and Rectal Surgery

Volumn 25, Issue 3, 2014, Pages 137-142

  Gilligan, Peter H ^a,b  

^a UNIVERSITY OF NORTH CAROLINA HOSPITALS   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL TOXIN; GLUTAMATE DEHYDROGENASE;

ARTICLE; BACTERIUM CULTURE; BACTERIUM DETECTION; CLOSTRIDIUM DIFFICILE INFECTION; DIARRHEA; FECES ANALYSIS; HUMAN; IMMUNOAFFINITY CHROMATOGRAPHY; INTERMETHOD COMPARISON; LABORATORY DIAGNOSIS; NONHUMAN; NUCLEIC ACID AMPLIFICATION; PROCESS OPTIMIZATION; SCREENING TEST; SENSITIVITY AND SPECIFICITY; TURNAROUND TIME;

EID: 84926217420     PISSN: 10431489     EISSN: 15584585     Source Type: Journal    
DOI: 10.1053/j.scrs.2014.05.008     Document Type: Article

References (55)

1. Bartlett J.G., Moon N., Chang T.W., et al. Role of Clostridium difficile in antibiotic-associated pseudomembranous colitis. Gastroenterology 1978, 75(5):778-782.
2. Shetty N., Wren M.W., Coen P.G. The role of glutamate dehydrogenase for the detection of Clostridium difficile in faecal samples: a meta-analysis. J Hosp Infect 2011, 77(1):1-6.
3. O'Horo J.C., Jones A., Sternke M., et al. Molecular techniques for diagnosis of Clostridium difficile infection: systematic review and meta-analysis. Mayo Clin Proc 2012, 87(7):643-651.
4. Deshpande A., Pasupuleti V., Rolston D.D., et al. Diagnostic accuracy of real-time polymerase chain reaction in detection of Clostridium difficile in the stool samples of patients with suspected Clostridium difficile infection: a meta-analysis. Clin Infect Dis 2011, 53(7):e81-e90.
5. Planche T., Aghaizu A., Holliman R., et al. Diagnosis of Clostridium difficile infection by toxin detection kits: a systematic review. Lancet Infect Dis 2008, 8(12):777-784.
6. Surawicz C.M., Brandt L.J., Binion D.G., et al. Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol 2013, 108(4):478-498.
7. Cheng A.C., Ferguson J.K., Richards M.J., et al. Australasian Society for Infectious Diseases guidelines for the diagnosis and treatment of Clostridium difficile infection. Med J Aust 2011, 194(7):353-358.
8. Cohen S.H., Gerding D.N., Johnson S., et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 2010, 31(5):431-455.
9. Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States; 2013.
10. Longtin Y., Trottier S., Brochu G., et al. Impact of the type of diagnostic assay on Clostridium difficile infection and complication rates in a mandatory reporting program. Clin Infect Dis 2013, 56(1):67-73.
11. Lyerly D.M., Krivan H.C., Wilkins T.D. Clostridium difficile: its disease and toxins. Clin Microbiol Rev 1988, 1(1):1-18.
12. Voth D.E., Ballard J.D. Clostridium difficile toxins: mechanism of action and role in disease. Clin Microbiol Rev 2005, 18(2):247-263.
13. Lyras D., O'Connor J.R., Howarth P.M., et al. Toxin B is essential for virulence of Clostridium difficile. Nature 2009, 458(7242):1176-1179.
14. Kuehne S.A., Cartman S.T., Heap J.T., et al. The role of toxin A and toxin B in Clostridium difficile infection. Nature 2010, 467(7316):711-713.
15. Chang T.W., Lin P.S., Gorbach S.L., et al. Ultrastructural changes of cultured human amnion cells by Clostridium difficile toxin. Infect Immun 1979, 23(3):795-798.
16. Peterson L.R., Mehta M.S., Patel P.A., et al. Laboratory testing for Clostridium difficile infection: light at the end of the tunnel. Am J Clin Pathol 2011, 136(3):372-380.
17. George W.L., Sutter V.L., Citron D., et al. Selective and differential medium for isolation of Clostridium difficile. J Clin Microbiol 1979, 9(2):214-219.
18. Marler L.M., Siders J.A., Wolters L.C., et al. Comparison of five cultural procedures for isolation of Clostridium difficile from stools. J Clin Microbiol 1992, 30(2):514-516.
19. Coltella L., Mancinelli L., Onori M., et al. Advancement in the routine identification of anaerobic bacteria by MALDI-TOF mass spectrometry. Eur J Clin Microbiol Infect Dis 2013, 32(9):1183-1192.
20. Boone J.H., Goodykoontz M., Rhodes S.J., et al. Clostridium difficile prevalence rates in a large healthcare system stratified according to patient population, age, gender, and specimen consistency. Eur J Clin Microbiol Infect Dis 2011, 31(7):1551-1559.
21. Lyerly D.M., Barroso L.A., Wilkins T.D. Identification of the latex test-reactive protein of Clostridium difficile as glutamate dehydrogenase. J Clin Microbiol 1991, 29(11):2639-2642.
22. Fille M., Larcher C., Dierich M.P., et al. Evaluation of four methods for detection of Clostridium difficile or C. difficile toxin: cytotoxin assay, culture, latex agglutination, and a new rapid immunoassay (C. difficile toxin A test). Z Gastroenterol 1998, 36(2):143-149.
23. Wu T.C., Fung J.C. Evaluation of the usefulness of counterimmunoelectrophoresis for diagnosis of Clostridium difficile-associated colitis in clinical specimens. J Clin Microbiol 1983, 17(4):610-613.
24. DiPersio J.R., Varga F.J., Conwell D.L., et al. Development of a rapid enzyme immunoassay for Clostridium difficile toxin A and its use in the diagnosis of C. difficile-associated disease. J Clin Microbiol 1991, 29(12):2724-2730.
25. Lyerly D.M., Lockwood D.E., Richardson S.H., et al. Biological activities of toxins A and B of Clostridium difficile. Infect Immun 1982, 35(3):1147-1150.
26. Alfa M.J., Kabani A., Lyerly D., et al. Characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile responsible for a nosocomial outbreak of Clostridium difficile-associated diarrhea. J Clin Microbiol 2000, 38(3):2706-2714.
27. Lyerly D.M., Neville L.M., Evans D.T., et al. Multicenter evaluation of the Clostridium difficile TOX A/B TEST. J Clin Microbiol 1998, 36(1):184-190.
28. Turgeon D.K., Novicki T.J., Quick J., et al. Six rapid tests for direct detection of Clostridium difficile and its toxins in fecal samples compared with the fibroblast cytotoxicity assay. J Clin Microbiol 2003, 41(2):667-670.
29. Landry M.L., Topal J., Ferguson D., et al. Evaluation of biosite triage Clostridium difficile panel for rapid detection of Clostridium difficile in stool samples. J Clin Microbiol 2001, 39(5):1855-1858.
30. Alfa M.J., Swan B., VanDekerkhove B., et al. The diagnosis of Clostridium difficile-associated diarrhea: comparison of Triage C. difficile panel, EIA for Tox A/B and cytotoxin assays. Diagn Microbiol Infect Dis 2002, 43(4):257-263.
31. Ticehurst J.R., Aird D.Z., Dam L.M., et al. Effective detection of toxigenic Clostridium difficile by a two-step algorithm including tests for antigen and cytotoxin. J Clin Microbiol 2006, 44(3):1145-1149.
32. Schmidt M.L., Gilligan P.H. Clostridium difficile testing algorithms: what is practical and feasible?. Anaerobe 2009, 15(6):270-273.
33. Burnham C.A., Carroll K.C. Diagnosis of Clostridium difficile infection: an ongoing conundrum for clinicians and for clinical laboratories. Clin Microbiol Rev 2013, 26(3):604-630.
34. Culbreath K., Ager E., Nemeyer R.J. Evolution of testing algorithms at a university hospital for detection of Clostridium difficile infections. J Clin Microbiol 2012, 50(9):3073-3075.
35. Kvach E.J., Ferguson D., Riska P.F., et al. Comparison of BD GeneOhm Cdiff real-time PCR assay with a two-step algorithm and a toxin A/B enzyme-linked immunosorbent assay for diagnosis of toxigenic Clostridium difficile infection. J Clin Microbiol 2010, 48(1):109-114.
36. Quinn C.D., Sefers S.E., Babiker W., et al. CDiff Quik Chek complete enzyme immunoassay provides a reliable first-line method for detection of Clostridium difficile in stool specimens. J Clin Microbiol 2010, 48(2):603-605.
37. Kutty P.K., Woods C.W., Sena A.C., et al. Risk factors for and estimated incidence of community-associated Clostridium difficile infection, North Carolina, USA. Emerg Infect Dis 2010, 16(2):197-204.
38. Viscidi R., Willey S., Bartlett J.G. Isolation rates and toxigenic potential of Clostridium difficile isolates from various patient populations. Gastroenterology 1981, 81(5):5-9.
39. Colarian J. Clostridium difficile colitis following antiviral therapy in the acquired immunodeficiency syndrome. Am J Med 1988, 84(8):1081.
40. Anand A., Glatt A.E. Clostridium difficile infection associated with antineoplastic chemotherapy: a review. Clin Infect Dis 1993, 17(1):109-113.
41. K. McCarthy, S. Johnston and C. Hepworth Clostridium difficile-associated colitis following the use of Chinese medicine, BMJ Case Rep 2009. Epub 2009 Feb 26. http://dx.doi.org/10.1136/bcr.08.2008.0716.
42. Brecher S.M., Novak-Weekley S.M., Nagy E. Laboratory diagnosis of Clostridium difficile infections: there is light at the end of the colon. Clin Infect Dis 2013, 57(8):1175-1181.
43. Dubberke E.R., Han Z., Bobo L., et al. Impact of clinical symptoms on interpretation of diagnostic assays for Clostridium difficile infections. J Clin Microbiol 2011, 49(8):2887-2893.
44. Khanna S., Pardi D.S., Rosenblatt J.E., et al. An evaluation of repeat stool testing for Clostridium difficile infection by polymerase chain reaction. J Clin Gastroenterol 2012, 46(10):846-849.
45. Nistico J.A., Hage J.E., Schoch P.E., et al. Unnecessary repeat Clostridium difficile PCR testing in hospitalized adults with C. difficile-negative diarrhea. Eur J Clin Microbiol Infect Dis 2012, 32(1):97-99.
46. Wenisch C., Parschalk B., Hasenhundl M., et al. Comparison of vancomycin, teicoplanin, metronidazole, and fusidic acid for the treatment of Clostridium difficile-associated diarrhea. Clin Infect Dis 1996, 22(5):813-818.
47. Loo V.G., Bourgault A.M., Poirier L., et al. Host and pathogen factors for Clostridium difficile infection and colonization. N Engl J Med 2011, 365(18):1693-1703.
48. Drekonja D.M., Butler M., MacDonald R., et al. Comparative effectiveness of Clostridium difficile treatments: a systematic review. Ann Intern Med 2011, 155(12):839-847.
49. Planche T.D., Davies K.A., Coen P.G., et al. Differences in outcome according to Clostridium difficile testing method: a prospective multicentre diagnostic validation study of C difficile infection. Lancet Infect Dis 2013, 13(11):936-945.
50. Polage C.R., Chin D.L., Leslie J.L., et al. Outcomes in patients tested for Clostridium difficile toxins. Diagn Microbiol Infect Dis 2012, 74(4):369-373.
51. SP-B Stool Pathogens Participant Summary 2013, College of American Pathology, Northfield, IL.
52. Wilcox M.H. Laboratory diagnosis of Clostridium difficile infection: in a state of transition or confusion or both?. J Hosp Infect 2011, 79(1):1-3.
53. Williamson D.A., Basu I., Freeman J., et al. Improved detection of toxigenic Clostridium difficile using the Cepheid Xpert C difficile assay and impact on C difficile infection rates in a tertiary hospital: a double-edged sword. Am J Infect Control 2012, 41(3):270-272.
54. Health Protection Agency, UK: voluntary surveillance of Clostridium difficile in England, Wales and Northern Ireland. 2012 Accessed 12.02.2014. http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1317138039648.
55. Schroeder L.F., Robilotti E., Peterson L.R., et al. Economic evaluation of laboratory testing strategies for hospital-associated Clostridium difficile infection. J Clin Microbiol 2014, 52(2):489-496.